ACannabis has established itself as a professional, credible industry event on the Australian medicinal cannabis calendar. Speakers, partners and delegates continue to rate the conference highly for format, content and organisation and we can’t wait to come back face to face in 2023.
Please join MCIA and industry colleagues for a fireside chat and networking function. Daniel Rooney (Insurance broker, Marsh) will be in conversation with Will Clarke (Underwriter, NewLine) to discuss Understanding Clinical Trials and Insurance Requirements. Will and Daniel will discuss the in’s and outs of clinical trials, where claims typically occur and how to make sure you have the right protection in place
ACannabis is back in 2022. With the theme, ‘Bridging the gap: evidence, confidence, access‘, ACannabis will be held over two jam packed days, Tuesday 15th March to Wednesday 16th March, and is the one location to stay up to date with all facets of the medicinal cannabis industry. Due to the ever changing landscape, ACannabis 2022 will be a virtual conference and exhibition with a wide range of networking opportunities available. It will be immersive, engaging and deliver an:
Please join us for the inaugural MCIA networking event to socialise, celebrate and contribute ideas for developing future networking events! Each occasion will include a speaker and presentation on a topic of interest to the industry.
MCIA is excited to invite you to an exclusive webinar hosted by FreshLeaf Analytics and AJD Media to present the H2 2021 FreshLeaf Analytics Market Report.
This report will be the 7th major publication from FreshLeaf, who has been covering the Australian medical cannabis industry since 2017, and is the leading source of information, data and insight on the sector.
Registration is now open for the TGA ‘Meeting Your Obligations – Supplying medicinal cannabis in Australia’ Workshop. MCIA has worked with TGA to deliver this workshop to assist members and others in the industry understand their obligations and specifically assist to understand the requirements for S3 over-the-counter (OTC) product registration requirements.
In launching ACannabis we noted that the medicinal cannabis industry is rapidly evolving, with many voices in the conversation. ACannabis is about harnessing the collective talent, knowledge and expertise that is critical to seize the opportunities in this exciting new industry which is providing an important new medicine for patients.
“ACannabis is the platform to gain a deep understanding of ground-breaking research, an inside perspective on global trends and a unique opportunity for the agritech and medtech sector to have the conversations required to leverage our advantages” Peter Crock, Chair Medicinal Cannabis Industry Australia
Around 70 members of parliament, government representatives, patient advocacy groups and industry participants gathered for the launch of the medicinal cannabis industry’s peak industry body – Medicinal Cannabis Industry Australia (MCIA).